Milestone Pharmaceuticals Inc. · NASDAQ:MIST

Trails Edge Capital Partners, LP reported a 9.90% stake in Milestone Pharmaceuticals Inc. (Schedule 13G)

Event Jul 14, 2025 · Filed Jul 21, 2025

Trails Edge Capital Partners, LP reported a 9.90% stake in Milestone Pharmaceuticals Inc., 8,847,882 shares, as a passive investor on Jul 14, 2025. Filed Jul 21, 2025 (Schedule 13G).

Stake
9.90%
Shares
8,847,882
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Trails Edge Capital Partners, LP9.90%8,847,882
Trails Edge Biotechnology Master Fund, LP9.90%8,847,882
Ortav Yehudai9.90%8,847,882

Source

View original at SEC

Related